Woodruff M F, Ghaffar A, Dunbar N, Whitehead V L
Br J Cancer. 1976 May;33(5):491-5. doi: 10.1038/bjc.1976.79.
S.c. injection of tumour cells or small pieces of tumour irradiated to a dose of 22,000 rad evoked resistance to live challenge with the same tumour (a CBA strain fibrosarcoma induced with methylcholanthrene) 14 days later. This resistance was, however, over-ridden if the challenging inoculum was sufficiently large, and did not develop if the cells were irradiated to 100,000 rad. The resistance evoked by injection of 10(6) irradiated tumour cells was impaired by i.p. injection of 1-4 mg C. parvum 5 days before, and virtually abolished by a similar injection 11 days after, the irradiated cells. The effect of s.c. injection of a mixture of 10(6) irradiated cells and C. parvum 14 days before live challenge depended on the dose of C. parvum. With 0-7 mg the development of resistance was largely but not completely abrogated; 0-35 mg resulted in a lesser degree of abrogation, and 0-09 mg or 0-02 mg had little or no effect.
皮下注射经22,000拉德剂量照射的肿瘤细胞或小块肿瘤,14天后可诱发对同一肿瘤(用甲基胆蒽诱导的CBA品系纤维肉瘤)活瘤攻击的抗性。然而,如果攻击接种物足够大,这种抗性就会被克服;如果细胞被照射至100,000拉德,则不会产生抗性。在注射10⁶个经照射的肿瘤细胞所诱发的抗性,在照射细胞前5天腹腔注射1 - 4毫克短小棒状杆菌会使其减弱,而在照射细胞后11天进行类似注射则几乎会将其消除。在活瘤攻击前14天皮下注射10⁶个经照射的细胞与短小棒状杆菌的混合物,其效果取决于短小棒状杆菌的剂量。注射0.7毫克时,抗性的产生在很大程度上但并非完全被消除;注射0.35毫克导致的消除程度较小,而注射0.09毫克或0.02毫克则几乎没有影响。